PPARA and fatty liver disease: In a high-fat diet-induced mouse model of fatty liver disease, the release of interleukin-1 beta (IL-1β) by KCs promotes hepatic steatosis by inhibiting peroxisome proliferator-activated receptor alpha (PPARα) activity in hepatocytes [7].